In vivo single cell analysis reveals Gata2 dynamics in cells transitioning to hematopoietic fate

Journal Article (2018)
Author(s)

Christina Eich (Erasmus MC)

Jochen Arlt (The University of Edinburgh)

Chris S. Vink (Queens Medical Research Institute, The University of Edinburgh)

Parham Solaimani Kartalaei (Erasmus MC)

Polynikis Kaimakis (Erasmus MC)

Samanta A. Mariani (The University of Edinburgh)

Reinier van der Linden (Erasmus MC)

Wiggert A. van Cappellen (Erasmus MC)

Elaine Dzierzak (The University of Edinburgh, Erasmus MC)

Affiliation
External organisation
DOI related publication
https://doi.org/10.1084/jem.20170807 Final published version
More Info
expand_more
Publication Year
2018
Language
English
Affiliation
External organisation
Journal title
Journal of Experimental Medicine
Issue number
1
Volume number
215
Pages (from-to)
233-248
Downloads counter
262

Abstract

Cell fate is established through coordinated gene expression programs in individual cells. Regulatory networks that include the Gata2 transcription factor play central roles in hematopoietic fate establishment. Although Gata2 is essential to the embryonic development and function of hematopoietic stem cells that form the adult hierarchy, little is known about the in vivo expression dynamics of Gata2 in single cells. Here, we examine Gata2 expression in single aortic cells as they establish hematopoietic fate in Gata2Venus mouse embryos. Time-lapse imaging reveals rapid pulsatile level changes in Gata2 reporter expression in cells undergoing endothelial-to-hematopoietic transition. Moreover, Gata2 reporter pulsatile expression is dramatically altered in Gata2+/- aortic cells, which undergo fewer transitions and are reduced in hematopoietic potential. Our novel finding of dynamic pulsatile expression of Gata2 suggests a highly unstable genetic state in single cells concomitant with their transition to hematopoietic fate. This reinforces the notion that threshold levels of Gata2 influence fate establishment and has implications for transcription factor-related hematologic dysfunctions.